Loading...
A retrospective analysis of actionable pharmacogenetic/genomic biomarker language in FDA labels
The primary goal of precision medicine is to maximize the benefit‐risk relationships for individual patients by delivering the right drug to the right patients at the right dose. To achieve this goal, it has become increasingly important to assess gene‐drug interactions (GDIs) in clinical settings....
Na minha lista:
| Udgivet i: | Clin Transl Sci |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8301579/ https://ncbi.nlm.nih.gov/pubmed/33742770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.13000 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|